256 related articles for article (PubMed ID: 9854445)
21. Vaccine adverse event reporting: the importance of follow-up.
Varricchio F
Expert Rev Vaccines; 2005 Aug; 4(4):445-8. PubMed ID: 16117700
[No Abstract] [Full Text] [Related]
22. Expedited safety reporting requirements for human drug and biological products; correction--FDA. Final rule; correction.
Fed Regist; 1998 Mar; 63(58):14611-2. PubMed ID: 10177754
[TBL] [Abstract][Full Text] [Related]
23. FDA's role in drug product recalls.
Crawford SY
Am J Hosp Pharm; 1991 Dec; 48(12):2595-6. PubMed ID: 1814194
[No Abstract] [Full Text] [Related]
24. US Food and Drug Administration: adverse event reporting.
Graham AA
CRNA; 1998 Nov; 9(4):135-8. PubMed ID: 9866488
[TBL] [Abstract][Full Text] [Related]
25. FDA's response to food, dietary supplement, and cosmetic adverse events.
Bren L
FDA Consum; 2003; 37(4):12-3. PubMed ID: 12971342
[No Abstract] [Full Text] [Related]
26. Toward improved adverse event/suspected adverse drug reaction reporting.
Gross R; Strom BL
Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):89-91. PubMed ID: 12642971
[No Abstract] [Full Text] [Related]
27. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule.
Fed Regist; 1998 May; 63(91):26069-77. PubMed ID: 10179334
[TBL] [Abstract][Full Text] [Related]
28. Drug withdrawals from the Canadian market for safety reasons, 1963-2004.
Lexchin J
CMAJ; 2005 Mar; 172(6):765-7. PubMed ID: 15767610
[No Abstract] [Full Text] [Related]
29. [FDA's new drug approval system].
Ishii A
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1146-51. PubMed ID: 7661565
[No Abstract] [Full Text] [Related]
30. When is a medical product too risky? An interview with FDA's top drug official. Interview by Tamar Nordenberg.
Woodcock J
FDA Consum; 1999; 33(5):8-11, 13. PubMed ID: 10522164
[No Abstract] [Full Text] [Related]
31. The FDA's sentinel initiative--A comprehensive approach to medical product surveillance.
Ball R; Robb M; Anderson SA; Dal Pan G
Clin Pharmacol Ther; 2016 Mar; 99(3):265-8. PubMed ID: 26667601
[TBL] [Abstract][Full Text] [Related]
32. [Withdrawal of cerivastatin revealed a flaw of post-marketing surveillance system in the United States].
Saito M; Hirata-Koizumi M; Miyake S; Hasegawa R
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2005; (123):41-5. PubMed ID: 16541751
[TBL] [Abstract][Full Text] [Related]
33. Improving the quality of adverse drug reaction reporting by 4th-year medical students.
Rosebraugh CJ; Tsong Y; Zhou F; Chen M; Mackey AC; Flowers C; Toyer D; Flockhart DA; Honig PK
Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):97-101. PubMed ID: 12642973
[TBL] [Abstract][Full Text] [Related]
34. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems.
Kessler DA
J Am Podiatr Med Assoc; 1994 Jan; 84(1):35-8. PubMed ID: 8295131
[No Abstract] [Full Text] [Related]
35. Consumer groups look to improve adverse event reporting systems.
Vastag B
J Natl Cancer Inst; 2005 Dec; 97(24):1804-5. PubMed ID: 16368939
[No Abstract] [Full Text] [Related]
36. Adverse drug reactions and reporting.
Witte R
Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100
[No Abstract] [Full Text] [Related]
37. Not enough warning. GAO report finds FDA's medical device monitoring lacking.
Hensley S
Mod Healthc; 1997 Mar; 27(10):102, 104. PubMed ID: 10165267
[No Abstract] [Full Text] [Related]
38. Cause and effect? Assessing postmarketing safety studies as evidence of causation in products liability cases.
Shea LL; Hanson A; Guglielmetti TM; Levy K
Food Drug Law J; 2007; 62(3):445-72. PubMed ID: 17915388
[No Abstract] [Full Text] [Related]
39. Strategy for surveillance of adverse drug events.
Bright RA
Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
[No Abstract] [Full Text] [Related]
40. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
